Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lemaitre Vascular (LMAT)

Lemaitre Vascular (LMAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lemaitre Vascular 63 SECOND AVENUE BURLINGTON MA 01803 USA

www.lemaitre.com Employees: 664 P: 781-221-2266 F: 781-425-5049

Sector:

Medical

Description:

LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.

Key Statistics

Overview:

Market Capitalization, $K 1,833,050
Enterprise Value, $K 1,807,440
Shares Outstanding, K 22,594
Annual Sales, $ 219,860 K
Annual Net Income, $ 44,040 K
Last Quarter Sales, $ 59,870 K
Last Quarter Net Income, $ 11,010 K
EBIT, $ 53,010 K
EBITDA, $ 62,680 K
60-Month Beta 0.83
% of Insider Shareholders 9.50%
% of Institutional Shareholders 84.64%
Float, K 20,448
% Float 90.50%
Short Volume Ratio 0.64

Growth:

1-Year Return 2.63%
3-Year Return 91.75%
5-Year Return 235.39%
5-Year Revenue Growth 87.55%
5-Year Earnings Growth 119.32%
5-Year Dividend Growth 88.24%

Per-Share Information:

Most Recent Earnings 0.48 on 05/01/25
Next Earnings Date 08/07/25
Earnings Per Share ttm 1.98
EPS Growth vs. Prev Qtr -2.04%
EPS Growth vs. Prev Year 9.09%
Annual Dividend Rate, $ 0.72
Annual Dividend Yield 0.89%
Most Recent Dividend 0.200 on 05/15/25
Next Ex-Dividends Date 05/15/25
Dividend Payable Date 05/29/25
Dividend Payout Ratio 33.90%

LMAT Ratios

Ratio
Price/Earnings ttm 41.10
Price/Earnings forward 37.57
Price/Earnings to Growth 2.15
Return-on-Equity % 13.53%
Return-on-Assets % 9.78%
Profit Margin % 20.03%
Debt/Equity 0.00
Price/Sales 8.36
Price/Cash Flow 34.06
Price/Book 5.29
Book Value/Share 15.39
Interest Coverage 271.86

LMAT Dividends

Date Value
05/15/25 $0.2000
03/13/25 $0.2000
11/21/24 $0.1600
08/15/24 $0.1600
05/15/24 $0.1600
03/13/24 $0.1600
11/15/23 $0.1400
08/16/23 $0.1400
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar